Onpattro 10 MG/5 ML vial 5ML
Ended Awarded
- Contract number
- SPE2DX25F6ABP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $14,187
Award facts
- Contract value 100% obligated
- $14,186.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $14,186.86 on July 21, 2025, for the supply of Onpattro (intravenous infusion medication) in 10 mg/5 ml vial format. This firm fixed-price delivery order, with an ultimate completion date of August 11, 2025, was issued without a set-aside designation by the Defense Logistics Agency's Medical Supply Chain division. The award represents a continuation of DMS Pharmaceutical Group's ongoing support to federal healthcare systems through its substantial Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026 under the SPE2DB program.
The delivery order fulfills the Defense Department's pharmaceutical supply requirements through DMS Pharmaceutical Group's established distribution network, which provides prescription medications, biologics, and medical consumables to military health facilities nationwide. As a consistently successful competitor in federal procurement markets, DMS Pharmaceutical Group leverages its woman-owned small business status and extensive pharmaceutical portfolio to maintain a critical role in the federal pharmaceutical supply chain, enabling timely delivery of specialized medications to Department of Defense healthcare sites across the United States.
Quick answers
Who was awarded contract SPE2DX25F6ABP?
SPE2DX25F6ABP was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on July 21, 2025.
How much is contract SPE2DX25F6ABP worth?
The government has obligated $14,187 on SPE2DX25F6ABP.
Is contract SPE2DX25F6ABP an order under another contract?
Yes. SPE2DX25F6ABP is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6ABP competed?
The extent of competition for SPE2DX25F6ABP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award